Odey Asset Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Odey Asset Management Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-36,700	Closed	-$2.32M	–	81
2021 Q1	$2.32M	Sell	36,700 -9,900	-21%	-$616K	0.65%	38
2020 Q4	$2.89M	Buy	46,600 +9,900	+27%	+$609K	0.74%	31
2020 Q3	$2.21M	Buy	36,700 +8,700	+31%	+$524K	0.3%	41
2020 Q2	$1.65M	Hold	28,000	–	–	0.28%	44
2020 Q1	$1.56M	Buy	+28,000	New	+$1.71M	0.26%	51
2019 Q3	–	Sell	-42,500	Closed	-$1.93M	–	55
2019 Q2	$1.93M	Hold	42,500	–	–	0.16%	47
2019 Q1	$2.03M	Buy	+42,500	New	+$2.12M	0.16%	47
2017 Q3	–	Sell	-24,500	Closed	-$1.36M	–	67
2017 Q2	$1.36M	Hold	24,500	–	–	0.15%	46
2017 Q1	$1.33M	Hold	24,500	–	–	0.14%	48
2016 Q4	$1.43M	Buy	+24,500	New	+$1.34M	0.15%	43
2016 Q3	–	Sell	-39,000	Closed	-$2.87M	–	84
2016 Q2	$2.87M	Sell	39,000 -31,000	-44%	-$2.19M	0.26%	39
2016 Q1	$4.47M	Buy	+70,000	New	+$4.41M	0.49%	27

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Odey Asset Management Group's BMY Position: Q2 2021 in Review

Odey Asset Management Group sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 36,700 shares — an estimated $2.32M sold.

Odey Asset Management Group first reported a position in BMY in Q1 2016 and held it in 12 quarters. The position peaked at $4.47M in Q1 2016. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

Odey Asset Management Group reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
Odey Asset Management Group sold 36,700 Bristol-Myers Squibb shares in Q2 2021, an estimated $2.32M.
Odey Asset Management Group first reported a position in Bristol-Myers Squibb in Q1 2016 and held it in 12 quarters.
Odey Asset Management Group's Bristol-Myers Squibb position peaked at $4.47M in Q1 2016.
2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Odey Asset Management Group's 13F filing for Q2 2021, filed 16 Aug 2021.